Tenaya Therapeutics

TNYA43

Penny Stock

$2.19arrow_drop_up8.41%$0.17

Penny Stock

TNYA43

$2.19

arrow_drop_up8.41%$0.17

Penny Stock

Performance History

There's no data available for key stats

There's no data available for ratios/profitability stats

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Tenaya Therapeutics (TNYA)

Tenaya Therapeutics, Inc. (TNYA) is a biotechnology company focused on discovering and developing novel treatments for heart disease. With a mission to transform the treatment of cardiovascular disease, Tenaya is leveraging cutting-edge science and technology to address significant unmet needs in this field. The company's innovative approach combines deep expertise in cardiovascular biology with advanced genomic engineering techniques to develop potentially curative therapies.

Tenaya Therapeutics, Inc. is driven by a vision of a future where cardiovascular diseases, such as heart failure and genetic cardiomyopathies, can be effectively treated or even reversed. Through its pioneering research, the company aims to unlock a new era of precision medicine for patients suffering from these conditions. By understanding the genetic basis of cardiovascular disease and developing therapies that target the underlying causes at a molecular level, Tenaya is working towards transformative advancements in patient care.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Faraz Ali M.B.A.
Headquarters: South San Francisco
Employees: 141
Exchange: NASDAQ

Keep an eye on Tenaya Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Tenaya Therapeutics's (TNYA) price per share?

The current price per share for Tenaya Therapeutics (TNYA) is $2.19. The stock has seen a price change of $0.17 recently, indicating a 8.42% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Tenaya Therapeutics (TNYA)?

For Tenaya Therapeutics (TNYA), the 52-week high is $7.01, which is 220.09% from the current price. The 52-week low is $1.66, the current price is 31.93% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Tenaya Therapeutics (TNYA) a growth stock?

Tenaya Therapeutics (TNYA) has shown an average price growth of 0.41% over the past three years. It has received a score of 16 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Tenaya Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Tenaya Therapeutics (TNYA) stock price performance year to date (YTD)?

As of the latest data, Tenaya Therapeutics (TNYA) has a year-to-date price change of -31.99%. Over the past month, the stock has experienced a price change of -25.76%. Over the last three months, the change has been -31.35%. Over the past six months, the figure is -51.66%.

help

Is Tenaya Therapeutics (TNYA) a profitable company?

Tenaya Therapeutics (TNYA) has a net income of -$124.08M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$131.19M. Furthermore, the EBITDA is -$118.31M.

help

What is the market capitalization of Tenaya Therapeutics (TNYA)?

Tenaya Therapeutics (TNYA) has a market capitalization of $171.94M. The average daily trading volume is 492.72K, indicating the stock's liquidity and investor engagement.

News

Tenaya Therapeutics Announces Research Leadership Updates

MANAGEMENT CHANGES

DIRECTORS AND OFFICERS

6/27/2024

Tenaya Therapeutics Announces Research Leadership Updates

Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit

CALENDAR OF EVENTS

HEALTH

CONFERENCE CALLS/ WEBCASTS

6/18/2024

Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit

Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

EARNINGS RELEASES AND OPERATING RESULTS

5/14/2024

Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting

CALENDAR OF EVENTS

HEALTH

PRODUCT / SERVICES ANNOUNCEMENT

5/2/2024

Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting